ahlam1399
09-22-2016, 02:00 AM
Lawmakers grill Mylan CEO over EpiPen steep price increases
WASHINGTON (Reuters) - U.S. lawmakers on Wednesday blasted steep price increases for Mylan's EpiPen emergency allergy treatment as they grilled the company's Chief Executive Heather Bresch at a congressional hearing. The House Committee on Oversight and Government Reform called Bresch to testify after the company raised the list price for a pair of EpiPens to $600 compared with $100 in 2007, when it acquired the product.http://feeds.feedburner.com/~ff/reuters/topNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/topNews?a=j6q0K1CWj3c:fSelhaM3F-Q:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/topNews?i=j6q0K1CWj3c:fSelhaM3F-Q:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/topNews?a=j6q0K1CWj3c:fSelhaM3F-Q:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/topNews?i=j6q0K1CWj3c:fSelhaM3F-Q:-BTjWOF_DHI (http://feeds.reuters.com/~ff/reuters/topNews?a=j6q0K1CWj3c:fSelhaM3F-Q:-BTjWOF_DHI)
http://feeds.feedburner.com/~r/reuters/topNews/~4/j6q0K1CWj3c
WASHINGTON (Reuters) - U.S. lawmakers on Wednesday blasted steep price increases for Mylan's EpiPen emergency allergy treatment as they grilled the company's Chief Executive Heather Bresch at a congressional hearing. The House Committee on Oversight and Government Reform called Bresch to testify after the company raised the list price for a pair of EpiPens to $600 compared with $100 in 2007, when it acquired the product.http://feeds.feedburner.com/~ff/reuters/topNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/topNews?a=j6q0K1CWj3c:fSelhaM3F-Q:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/topNews?i=j6q0K1CWj3c:fSelhaM3F-Q:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/topNews?a=j6q0K1CWj3c:fSelhaM3F-Q:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/topNews?i=j6q0K1CWj3c:fSelhaM3F-Q:-BTjWOF_DHI (http://feeds.reuters.com/~ff/reuters/topNews?a=j6q0K1CWj3c:fSelhaM3F-Q:-BTjWOF_DHI)
http://feeds.feedburner.com/~r/reuters/topNews/~4/j6q0K1CWj3c